LDL particle subclasses in hypercholesterolemia: Molecular determinants of reduced lipid hydroperoxide stability

Journal of Lipid Research

Volumn 43, Issue 3, 2002, Pages 453-462

  Chancharme, Laurent ^a,b   Thérond, Patrice ^c   Nigon, Fabienne ^a,b   Zarev, Stéphanie ^c   Mallet, Alain ^a   Bruckert, Eric ^a,b   John Chapman, M ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Inst Federatif de Rech 49   (France)

^c BICÊTRE HOSPITAL   (France)

Author keywords

ApoB 100 conformation; Atherogenicity; Cholesteryl ester hydroperoxide stability; Copper mediated oxidation; Light, intermediate, and dense LDL; Lipophilic antioxidants; Oxidative stress; Polyunsaturated cholesteryl ester tocopherol ratio; Surface phospholipid free cholesterol ratio

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN B100; CHOLESTEROL; CHOLESTEROL ESTER; LIPID HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID;

ADULT; ARTERY WALL; ARTICLE; ATHEROGENESIS; CHEMICAL COMPOSITION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FATTY ACID OXIDATION; FEMALE; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; OXIDATIVE STRESS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN CONFORMATION; SPECTROPHOTOMETRY;

APOLIPOPROTEIN B-100; APOLIPOPROTEINS B; CHOLESTEROL ESTERS; COPPER; ESTERIFICATION; FATTY ACIDS; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LIPID PEROXIDES; LIPOPROTEINS, LDL; MALE; OXIDATION-REDUCTION; PARTICLE SIZE; PHOSPHATIDYLCHOLINES; PHOSPHOLIPIDS;

EID: 0036208452     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Why are low-density lipoproteins atherogenic?
2. Relation between low-density lipoprotein cholesterol and thoracic aortic atherosclerosis
3. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study
4. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches
5. Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk
6. Further resolution of the low density lipoprotein spectrum in normal human plasma: Physicochemical characteristics of discrete subspecies separated by density gradient ultracentrifugation
7. Preferential cholesteryl ester acceptors among the LDL subspecies of subjects with familial hypercholesterolemia
8. Further resolution and comparison of the heterogeneity of plasma low-density lipoproteins in human hyperlipoproteinemias: Type III hyperlipoproteinemia, hypertriglyceridemia and familial hypercholesterolemia
9. Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis
10. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity
11. Physiological aspects of low-density lipoprotein oxidation
12. Evidence for the presence of oxidatively modified low, density lipoprotein in atherosclerotic lesions of rabbit and man
13. Hypercholesterolemia increases endothelial superoxide anion production
14. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man
15. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions
16. The role of lipid peroxidation and antioxidants in oxidative modification of LDL
17. Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation
18. Rapid isolation of lipoproteins and assessment of their peroxidation by high-performance liquid chromatography postcolumn chemiluminescence
19. Cholesteryl ester hydroperoxide lability is a key feature of the oxidative susceptibility of small, dense LDL
20. The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis
21. Oxidation of free fatty acids in low density lipoprotein by 15-lipoxygenase stimulates nonenzymic, alpha-tocopherol-mediated peroxidation of cholesteryl esters
22. Time course of oxysterol formation during in vitro oxidation of low density lipoprotein
23. The susceptibility of low-density lipoprotein to in vitro oxidation is increased in hypercholesterolemic patients
24. Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients
25. Diminished susceptibility to in vitro oxidation of low-density lipoproteins in hypercholesterolemia: Key role of alpha-tocopherol content
26. Susceptibility of low density lipoprotein to oxidation in familial hypercholesterolaemia
27. Decreased resistance against in vitro oxidation of LDL from patients with familial defective apolipoprotein B-100
28. Autoxidation of human low density lipoprotein: Loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes
29. Low density lipoprotein oxidizability by copper correlates to its initial ubiquinol-10 and polyunsaturated fatty acid content
30. Fatty acid composition of low-density lipoprotein influences its susceptibility to autoxidation
31. Greater oxidative susceptibility of the surface monolayer in small dense LDL may contribute to differences in copper-induced oxidation among LDL density subfractions
32. Plasma LDL and HDL subspecies are heterogenous in particle content of tocopherols and oxygenated and hydrocarbon carotenoids. Relevance to oxidative resistance and atherogenesis
33. Continuous monitoring of intermediates and final products of oxidation of low density lipoprotein by means of UV-spectroscopy
34. Simultaneous determination of the main molecular species of soybean phosphatidylcholine or phosphatidylethanolamine and their corresponding hydroperoxides obtained by lipoxygenase treatment
35. Apolipoprotein B carbonyl formation is enhanced by lipid peroxidation during copper-mediated oxidation of human low-density lipoproteins
36. Nonenzymatic oxidative cleavage of peptide bonds in apoprotein B-100
37. Dietary and pharmacological antioxidants in atherosclerosis
38. Tocopherol-mediated peroxidation: The pro-oxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein
39. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha-tocopherol and ascorbate
40. Coexistence of oxidized lipids and alpha-tocopherol in all lipoprotein density fractions isolated from advanced human atherosclerotic plaques
41. Dissociation of atherogenesis from aortic accumulation of lipid hydro (pero)xides in Watanabe heritable hyperlipidemic rabbits
42. How different constituents of low density lipoprotein determine its oxidizability by copper: A correlational approach
43. Another cholesterol hypothesis: Cholesterol as antioxidant
44. Reduction of lipid hydroperoxides by apolipoprotein B-100
45. Detection of oxidized phospholipid-protein adducts using anti-15-hydroperoxyeicosatetraenoic acid-modified protein antibody: Contribution of esterified fatty acid-protein adduct to oxidative modification of LDL
46. Conformational differences in human apolipoprotein B-100 among subspecies of low density lipoproteins (LDL). Association of altered proteolytic accessibility with decreased receptor binding of LDL subspecies from hypertriglyceridemic subjects
47. Apolipoprotein B-100 conformation and particle surface charge in human LDL subspecies: Implication for LDL receptor interaction
48. Predominance of large LDL and reduced HDL2 cholesterol in normolipidemic men with coronary artery disease
49. Low-density lipoprotein particle composition: What is the contribution to atherogenicity?
50. Cytotoxicity of phosphatidylcholine hydroperoxides is exerted through decomposition of fatty acid hydroperoxide moiety